Brief: Huakang Biomedical Trading In Co's Shares Halted
Oct 9 (Reuters) - Huakang Biomedical 8622.HK: TRADING IN CO'S SHARES ON GEM HKEX TO BE HALTED ON 9 OCT Further company coverage: 8622.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Joyzyme
See all newsChairman
Brief: Huakang Biomedical Trading In Co's Shares Halted
Brief: Huakang Biomedical Says Zhang Shuguang Resigns As Executive Director And Chairman
Brief: Huakang Biomedical Announces Zhang Yujing Appointed As Executive Director
Brief: Huakang Biomedical To Acquire 51% Interest In Hunan Keyue Biotechnology